If your medical tools resemble those found in the doctor’s bag of yore, consider elevating your treatment style–and your own quality of life–and look to these gadgets for a new level of precision and care. Reliable devices still exist and should be used – but have you upgraded your arsenal recently? Discover the essential technology […]
In Study CK-301-101, the primary efficacy endpoint was objective response rate (complete + partial response, by independent central review), which was 47% (n = 15) in 32 mCSCC patients evaluable for response, including 3 complete responses and 12 partial responses. The results from the study were presented at the ESMO Congress.
In this research article, the authors demonstrate a simple optical measurement method to evaluate the efficacy of masks to reduce the transmission of respiratory droplets during regular speech. They tested 14 commonly available masks or masks alternatives, one patch of mask material, and a professionally fit-tested N95 mask.
In this podcast, Dr. Jennifer Caudle speaks with Drs. Kathryn Ruddy and Joerg Herrmann from the cardio-oncology clinic at the Mayo Clinic to talk about the field that’s devoted to improving cardiovascular health both during and after cancer therapy.
The Journal of Clinical Oncology published the double-blind, phase 3 KEYNOTE-604 clinical trial study results, which sought to compare pembrolizumab plus etoposide and platinum (EP) with placebo plus EP in treatment-naïve patients with ES-SCLC.
Although the findings reported in Blood should be considered as hypothesis-generating and preliminary in nature, a small clinical trial suggested ibrutinib may protect against lung injury and improve pulmonary function in hypoxic patients with COVID-19.